68 Investor presentation First three months of 2021 Solid commercial execution is dri Historic reported sales for Norditropin ® Norditropin ® value despite incre DKK billion 40% 8% 14% -22% 7% 2% 8% 9 30% 6 20% 3 10% 0 2015 2016 2017 2018 2019 2020 Norditropin® Growth at CER 1 Based on assessment from Nov 2019 Note: Company reported sales; CER: Constant exchange rates 0% Feb 2016 Novo No Eli Lilly Merck Kg Other Note: IQVIA, MAT value DKK, Feb
Download PDF file